rotenone

rotenone is a lipid of Polyketides (PK) class. Rotenone is associated with abnormalities such as Parkinson Disease, MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET, Neurodegenerative Disorders, Septicemia and Respiratory Failure. The involved functions are known as Phosphorylation, Process, Cell Death, proteasome activity and Apoptosis. Rotenone often locates in Protoplasm, Presynaptic Terminals, Neurites, NADH dehydrogenase complex and Mitochondria. The associated genes with rotenone are DNAJB9 gene, EIF2S3 gene, Candidate Disease Gene, G-substrate and ERN1 gene. The related lipids are Lipopolysaccharides, Membrane Lipids, Phosphatidylserines, Fatty Acids and Cardiolipins. The related experimental models are Knock-out, Mouse Model, Disease model and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of rotenone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with rotenone?

rotenone is suspected in Parkinson Disease, Ischemia, Parkinsonian Disorders, Renal tubular disorder, Morphologically altered structure, Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with rotenone

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Per page 10 20 50 100 | Total 87

PubChem Associated disorders and diseases

What pathways are associated with rotenone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with rotenone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with rotenone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with rotenone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with rotenone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with rotenone?

Knock-out

Knock-out are used in the study 'Functional relevance of the histone gammaH2Ax in the response to DNA damaging agents.' (Revet I et al., 2011).

Mouse Model

Mouse Model are used in the study 'Inhibitors of metabolism rescue cell death in Huntington's disease models.' (Varma H et al., 2007) and Mouse Model are used in the study 'Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion.' (Nair AS et al., 2006).

Rodent Model

Rodent Model are used in the study 'Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels.' (Worth AJ et al., 2014) and Rodent Model are used in the study 'The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease.' (Hwang RD et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with rotenone

Download all related citations
Per page 10 20 50 100 | Total 3666
Authors Title Published Journal PubMed Link
Liang S et al. GAPDH-knockdown reduce rotenone-induced H9C2 cells death via autophagy and anti-oxidative stress pathway. 2015 Toxicol. Lett. pmid:25725130
Khalil WK et al. Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. 2015 Neurochem. Int. pmid:25481089
Nassar NN et al. Saxagliptin: a novel antiparkinsonian approach. 2015 Neuropharmacology pmid:25446674
Tyurina YY et al. LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease. 2015 Free Radic. Res. pmid:25740198
Parameshwaran K et al. Antioxidant-mediated reversal of oxidative damage in mouse modeling of complex I inhibition. 2015 Drug Dev. Res. pmid:25847731
Dalu T et al. An Assessment of the Effect of Rotenone on Selected Non-Target Aquatic Fauna. 2015 PLoS ONE pmid:26540301
Bundela S et al. Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine. 2015 PLoS ONE pmid:26536350
Forkink M et al. Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells. 2015 Redox Biol pmid:26516986
Ojha S et al. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease. 2015 Drug Des Devel Ther pmid:26504373
Xia N et al. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model. 2015 Free Radic. Biol. Med. pmid:26454081
Kabiraj P et al. The neuroprotective role of ferrostatin-1 under rotenone-induced oxidative stress in dopaminergic neuroblastoma cells. 2015 Protein J. pmid:26385697
Nojima Y et al. Superoxide dismutases, SOD1 and SOD2, play a distinct role in the fat body during pupation in silkworm Bombyx mori. 2015 PLoS ONE pmid:25714339
Liang Y et al. Toxicity of amorphigenin from the seeds of Amorpha fruticosa against the larvae of Culex pipiens pallens (Diptera: Culicidae). 2015 Molecules pmid:25690287
Xu Q et al. Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation. 2015 Breast Cancer Res. Treat. pmid:25677747
Yin L et al. The S-nitrosylation status of PCNA localized in cytosol impacts the apoptotic pathway in a Parkinson's disease paradigm. 2015 PLoS ONE pmid:25675097
Goldstein DS et al. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease. 2015 J. Neurochem. pmid:25645689
Murakami S et al. Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice. 2015 Neurochem. Res. pmid:25894684
Cappelletti G et al. Linking microtubules to Parkinson's disease: the case of parkin. 2015 Biochem. Soc. Trans. pmid:25849932
Hsu CG and Burkholder TJ Activation of p38 in C2C12 myotubes following ATP depletion depends on extracellular glucose. 2015 J. Physiol. Biochem. pmid:25835326
Lagido C et al. A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans. 2015 J Vis Exp pmid:26554627
Nascimento C et al. Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction. 2015 J Neural Transm (Vienna) pmid:25261015
Yi S et al. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation. 2015 Ann. Hematol. pmid:25242579
Trask OJ et al. A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis. 2014 Jan-Feb Assay Drug Dev Technol pmid:24444127
Nguyen HT and Chen M High-energy compounds mobilize intracellular Ca2+ and activate calpain in cultured cells: is calpain an energy-dependent protease? 2014 Brain Res. Bull. pmid:24508187
Kavitha M et al. Mangiferin antagonizes rotenone: induced apoptosis through attenuating mitochondrial dysfunction and oxidative stress in SK-N-SH neuroblastoma cells. 2014 Neurochem. Res. pmid:24493626
Wang H et al. The contribution of Cdc2 in rotenone-induced G2/M arrest and caspase-3-dependent apoptosis. 2014 J. Mol. Neurosci. pmid:24337984
Thakur P and Nehru B Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson's disease in a rotenone-based model. 2014 Neuropharmacology pmid:24296154
Ma KL et al. The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle. 2014 Neuropharmacology pmid:23973294
Kabiraj P et al. Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers. 2014 ACS Chem Neurosci pmid:25247703
Ai Q et al. Rotenone, a mitochondrial respiratory complex I inhibitor, ameliorates lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice. 2014 Int. Immunopharmacol. pmid:24830863
Zhang Q et al. Involvement of ERK1/2 pathway in neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury. 2014 Neuroscience pmid:24755484
Ouazia D et al. Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells. 2014 Neuroscience pmid:24631677
Zhang X et al. Puerarin protects dopaminergic neurons in Parkinson's disease models. 2014 Neuroscience pmid:25218963
Cleaver JE et al. Mitochondrial reactive oxygen species are scavenged by Cockayne syndrome B protein in human fibroblasts without nuclear DNA damage. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25136123
Krug AK et al. Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+). 2014 Cell Death Dis pmid:24810058
Rojas-Charry L et al. Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells. 2014 Neurotoxicology pmid:24792327
Mansergh FC et al. Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy. 2014 Eur. J. Hum. Genet. pmid:24569607
Brouillette MJ et al. Strain-dependent oxidant release in articular cartilage originates from mitochondria. 2014 Biomech Model Mechanobiol pmid:23896937
Kim JH et al. Hypoxia induces adipocyte differentiation of adipose-derived stem cells by triggering reactive oxygen species generation. 2014 Cell Biol. Int. pmid:23956071
Zhu M et al. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. 2014 CNS Neurosci Ther pmid:24351065
Hughes RH et al. Neuroprotection by genipin against reactive oxygen and reactive nitrogen species-mediated injury in organotypic hippocampal slice cultures. 2014 Brain Res. pmid:24275198
Lim J et al. Impaired autophagic flux is critically involved in drug-induced dopaminergic neuronal death. 2014 Parkinsonism Relat. Disord. pmid:24262172
Qualls Z et al. Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease. 2014 Neurotox Res pmid:24122264
Di Filippo M et al. Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence. 2014 Neurobiol. Dis. pmid:24135008
Du C et al. Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type. 2014 Biochem. Biophys. Res. Commun. pmid:25086357
Mtimunye PJ and Chirwa EM Characterization of the biochemical-pathway of uranium (VI) reduction in facultative anaerobic bacteria. 2014 Chemosphere pmid:25065785
Bueno Pérez L et al. Caeruleanone A, a rotenoid with a new arrangement of the D-ring from the fruits of Millettia caerulea. 2014 Org. Lett. pmid:24552419
Imbeault E et al. Nlrx1 regulates neuronal cell death. 2014 Mol Brain pmid:25540124
Corona JC et al. PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. 2014 Exp. Neurol. pmid:24374061
Shi YL et al. Mitochondrial inhibitor sensitizes non-small-cell lung carcinoma cells to TRAIL-induced apoptosis by reactive oxygen species and Bcl-X(L)/p53-mediated amplification mechanisms. 2014 Cell Death Dis pmid:25522273
Pal R et al. Rotenone induces neurotoxicity through Rac1-dependent activation of NADPH oxidase in SHSY-5Y cells. 2014 FEBS Lett. pmid:24374334
Tang G et al. Comparison of several supervised pattern recognition techniques for detecting additive methamidophos in rotenone preparation by near-infrared spectroscopy. 2014 Spectrochim Acta A Mol Biomol Spectrosc pmid:24368288
Parmigiani A et al. Sestrins inhibit mTORC1 kinase activation through the GATOR complex. 2014 Cell Rep pmid:25457612
Gruber J et al. Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production. 2014 Bioorg. Med. Chem. pmid:24393721
Upegui Y et al. Preparation of rotenone derivatives and in vitro analysis of their antimalarial, antileishmanial and selective cytotoxic activities. 2014 Molecules pmid:25412039
Deng Y and Lu J [Role of rotenone in mitochondrial oxidative damage and the underlying mechanisms]. 2014 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:25355263
Agarwal B et al. Isoflurane modulates cardiac mitochondrial bioenergetics by selectively attenuating respiratory complexes. 2014 Biochim. Biophys. Acta pmid:24355434
Shang HS et al. Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro. 2014 Molecules pmid:25322282
Knaryan VH et al. SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone. 2014 J. Neurochem. pmid:24341912
Gong LL et al. Protective effects of Akebia saponin D against rotenone-induced hepatic mitochondria dysfunction. 2014 J. Pharmacol. Sci. pmid:25319614
Wu MM et al. Polygalasaponin F against rotenone-induced apoptosis in PC12 cells via mitochondria protection pathway. 2014 J Asian Nat Prod Res pmid:24382325
Bird MJ et al. Neuronal and astrocyte dysfunction diverges from embryonic fibroblasts in the Ndufs4fky/fky mouse. 2014 Biosci. Rep. pmid:25312000
Zhou Y et al. Effect of two formulations on the decline curves and residue levels of rotenone in cabbage and soil under field conditions. 2014 Ecotoxicol. Environ. Saf. pmid:24632119
Wang H et al. Cell cycle regulation of DNA polymerase beta in rotenone-based Parkinson's disease models. 2014 PLoS ONE pmid:25303312
Lin TK et al. Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. 2014 Int J Mol Sci pmid:24451142
Wang HS et al. In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila. 2014 Mol Brain pmid:25288323
Rao DK et al. A combination of curcumin with either gramicidin or ouabain selectively kills cells that express the multidrug resistance-linked ABCG2 transporter. 2014 J. Biol. Chem. pmid:25253691
Sanders LH et al. Mitochondrial DNA damage as a peripheral biomarker for mitochondrial toxin exposure in rats. 2014 Toxicol. Sci. pmid:25237061
Basukriadi A and Wilkins RM Oviposition deterrent activities of Pachyrhizus erosus seed extract and other natural products on Plutella xylostella (Lepidoptera: Plutellidae). 2014 J. Insect Sci. pmid:25525107
Murakami S et al. Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice. 2014 Neurotox Res pmid:24923464
Xiao F et al. Role of mitochondrial electron transport chain dysfunction in Cr(VI)-induced cytotoxicity in L-02 hepatocytes. 2014 Cell. Physiol. Biochem. pmid:24732427
Xu Y et al. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease. 2014 Cell. Signal. pmid:24726895
Jing X et al. Rifampicin protects PC12 cells from rotenone-induced cytotoxicity by activating GRP78 via PERK-eIF2α-ATF4 pathway. 2014 PLoS ONE pmid:24638036
Jia F et al. Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice. 2014 PLoS ONE pmid:24618574
Mor A et al. Singlet oxygen signatures are detected independent of light or chloroplasts in response to multiple stresses. 2014 Plant Physiol. pmid:24599491
Li DL et al. Glibenclamide decreases ATP-induced intracellular calcium transient elevation via inhibiting reactive oxygen species and mitochondrial activity in macrophages. 2014 PLoS ONE pmid:24558474
Prior S et al. Mitochondrial respiratory function induces endogenous hypoxia. 2014 PLoS ONE pmid:24586439
Han G et al. The mitochondrial complex I inhibitor rotenone induces endoplasmic reticulum stress and activation of GSK-3β in cultured rat retinal cells. 2014 Invest. Ophthalmol. Vis. Sci. pmid:25082888
Wallström SV et al. Suppression of NDA-type alternative mitochondrial NAD(P)H dehydrogenases in arabidopsis thaliana modifies growth and metabolism, but not high light stimulation of mitochondrial electron transport. 2014 Plant Cell Physiol. pmid:24486764
Willis GL et al. Parkinson's disease, lights and melanocytes: looking beyond the retina. 2014 Sci Rep pmid:24473093
Ju E et al. Near-infrared light-triggered drug-delivery vehicle for mitochondria-targeted chemo-photothermal therapy. 2014 ACS Appl Mater Interfaces pmid:24559457
Gupta SP et al. Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease? 2014 Mol. Neurobiol. pmid:23900742
Fernando P et al. Toxicological evaluation of a rotenone derivative in rodents for clinical myocardial perfusion imaging. 2014 Cardiovasc. Toxicol. pmid:24395712
Bienholz A et al. Substrate modulation of fatty acid effects on energization and respiration of kidney proximal tubules during hypoxia/reoxygenation. 2014 PLoS ONE pmid:24728405
Currie HN et al. An approach to investigate intracellular protein network responses. 2014 Chem. Res. Toxicol. pmid:24359296
Gao L et al. Discovery of the neuroprotective effects of alvespimycin by computational prioritization of potential anti-Parkinson agents. 2014 FEBS J. pmid:24304935
Li B et al. Flavin-containing monooxygenase, a new clue of pathological proteins in the rotenone model of parkinsonism. 2014 Neurosci. Lett. pmid:24440618
Dokleja L et al. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers. 2014 Neurosci. Lett. pmid:25240592
Balsera B et al. Chalcones as positive allosteric modulators of α7 nicotinic acetylcholine receptors: a new target for a privileged structure. 2014 Eur J Med Chem pmid:25232969
Noseda AC et al. Putative role of monoamines in the antidepressant-like mechanism induced by striatal MT2 blockade. 2014 Behav. Brain Res. pmid:25218873
Varga SJ et al. A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease. 2014 Brain Res. pmid:25130663
Milowska K et al. In vitro PAMAM, phosphorus and viologen-phosphorus dendrimers prevent rotenone-induced cell damage. 2014 Int J Pharm pmid:25108046
Jang W et al. 1,25-Dyhydroxyvitamin D₃ attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy. 2014 Biochem. Biophys. Res. Commun. pmid:25078626
Hemion C et al. Quality control of oxidatively damaged mitochondrial proteins is mediated by p97 and the proteasome. 2014 Free Radic. Biol. Med. pmid:25062828
Estrella-Parra EA et al. Rotenone isolated from Pachyrhizus erosus displays cytotoxicity and genotoxicity in K562 cells. 2014 Nat. Prod. Res. pmid:25055205
Ye H et al. Millettia pachycarpa exhibits anti-inflammatory activity through the suppression of LPS-induced NO/iNOS expression. 2014 Am. J. Chin. Med. pmid:25004885
Linghu L et al. Mirabijalone E: a novel rotenoid from Mirabilis himalaica inhibited A549 cell growth in vitro and in vivo. 2014 J Ethnopharmacol pmid:24882730
Zhang XY et al. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1. 2014 Brain Res. pmid:24858057
Thakur P and Nehru B Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology. 2014 Neurochem. Int. pmid:24852355
Yan JQ et al. Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway. 2014 Mol. Neurobiol. pmid:24833599